EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Guanylate binding protein 5 is an immune‐related biomarker of oral squamous cell carcinoma: A retrospective prognostic study with bioinformatic analysis

Masayo Hasegawa, Yusuke Amano iD, Atsushi Kihara, Daisuke Matsubara, Noriyoshi Fukushima, Hideyuki Takahashi, Kazuaki Chikamatsu, Hiroshi Nishino, Yoshiyuki Mori, Naohiro Yoshida, Toshiro Niki

Cancer Medicine · 2024

DOI: 10.1002/cam4.7431 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2024. Verfasst von Masayo Hasegawa und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Integrative Pathology, Jichi Medical University, Shimotsuke, Tochigi, Japan. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Computational Biology, Mouth Neoplasms, Tumor Microenvironment. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cancer utilizes immunosuppressive mechanisms to create a tumor microenvironment favorable for its progression. The purpose of this study is to histologically characterize the immunological properties of the tumor microenvironment of oral squamous cell carcinoma (OSCC) and identify key molecules involved in the immunological microenvironment and patient prognosis.

Methods

First, overlapping differentially expressed genes (DEGs) were screened from OSCC transcriptome data in public databases. Correlation analysis of DEGs with known immune‐related genes identified genes involved in the immune microenvironment of OSCC. Next, stromal patterns of tumor were classified and immunohistochemical staining was performed for immune cell markers (CD3, CD4, Foxp3, CD8, CD20, CD68, and CD163), programmed death‐ligand 1 (PD‐L1), and guanylate binding protein 5 (GBP5) in resected specimens obtained from 110 patients with OSCC who underwent resection. Correlations between each factor and their prognostic impact were analyzed.

Results

Among the novel OSCC‐specific immune‐related genes screened (including ADAMDEC1 , CXCL9 , CXCL13 , DPT , GBP5 , IDO1 , and PLA2G7 ), GBP5 was selected as the target gene. Histopathologic analysis showed that multiple T‐cell subsets and CD20‐positive cells were less common in the advanced stages, whereas CD163‐positive cells were more common in advanced stages. The immature type in the stromal pattern category was associated with less immune cell infiltration, lower expression of PD‐L1 in immune cells, lower expression of GBP5 in the stroma, and shorter overall survival and recurrence‐free survival. Expression of GBP5 in the tumor and stroma correlated with immune cell infiltration of tumors and PD‐L1 expression in tumor and immune cells. Patients with low tumor GBP5 expression and high stromal expression had significantly longer overall survival and recurrence‐free survival.

Conclusions

The stromal pattern category may reflect both invasive and immunomodulatory potentials of cancer‐associated fibroblasts in OSCC. GBP5 has been suggested as a potential biomarker to predict the prognosis and therapeutic efficacy of immune checkpoint inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biomarkers, TumorComputational BiologyMouth NeoplasmsTumor MicroenvironmentAdultAgedFemaleHumansMaleMiddle AgedB7-H1 AntigenCarcinoma, Squamous CellGene Expression Regulation, NeoplasticGTP-Binding ProteinsLymphocytes, Tumor-InfiltratingPrognosisRetrospective Studies

Stichwörter der Autor:innen

GBP5OSCCPD‐L1stromal pattern

Substanzen

B7-H1 AntigenBiomarkers, TumorGTP-Binding ProteinsGBP5 protein, human

Autor:innen und Institutionen

  • Department of Integrative Pathology, Jichi Medical University, Shimotsuke, Tochigi, Japan.
  • Department of Otolaryngology-Head and Neck Surgery, Jichi Medical University Saitama Medical Center, Saitama, Japan.
  • Department of Pathology, Faculty of medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
  • Department of Otolaryngology-Head and Neck Surgery, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan.
  • Department of Otolaryngology-Head and Neck Surgery, Jichi Medical University, Shimotsuke, Tochigi, Japan.
  • Department of Dentistry, Oral and Maxillofacial Surgery, Jichi Medical University Saitama Medical Center, Saitama, Japan.

ORCID-Profile: Yusuke Amano

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Hasegawa, M., Amano, Y., Kihara, A., Matsubara, D., Fukushima, N., Takahashi, H., Chikamatsu, K., Nishino, H., Mori, Y., Yoshida, N., & Niki, T. (2024). Guanylate binding protein 5 is an immune‐related biomarker of oral squamous cell carcinoma: A retrospective prognostic study with bioinformatic analysis. Cancer Medicine. https://doi.org/10.1002/cam4.7431

Vancouver

Hasegawa M, Amano Y, Kihara A, Matsubara D, Fukushima N, Takahashi H, et al. Guanylate binding protein 5 is an immune‐related biomarker of oral squamous cell carcinoma: A retrospective prognostic study with bioinformatic analysis. Cancer Medicine. 2024. doi:10.1002/cam4.7431

BibTeX
@article{Hasegawa2024,
  author = {Hasegawa, Masayo and Amano, Yusuke and Kihara, Atsushi and Matsubara, Daisuke and Fukushima, Noriyoshi and Takahashi, Hideyuki and Chikamatsu, Kazuaki and Nishino, Hiroshi and Mori, Yoshiyuki and Yoshida, Naohiro and Niki, Toshiro},
  title = {Guanylate binding protein 5 is an immune‐related biomarker of oral squamous cell carcinoma: A retrospective prognostic study with bioinformatic analysis},
  journal = {Cancer Medicine},
  year = {2024},
  doi = {10.1002/cam4.7431}
}
Kostenlos starten →